Quest Diagnostics (DGX) Market Capitalization (2009 - 2026)

Quest Diagnostics has disclosed Market Capitalization across 18 years of filings, most recently posting $23.4 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 16.46% year-over-year to $23.4 billion; the TTM figure through Jun 2026 stood at $23.4 billion (up 16.46% YoY), while the FY2025 annual figure was $19.1 billion, up 13.87% from the prior year.
• Market Capitalization came in at $23.4 billion for Q2 2026 at Quest Diagnostics, up from $21.7 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $23.4 billion in Q2 2026 to a low of $13.7 billion in Q3 2023.
• Average Market Capitalization over 5 years is $17.3 billion, with a median of $16.4 billion recorded in 2022.
• Year-over-year, Market Capitalization slipped 21.61% in 2022 and surged 31.83% in 2025.
• Over 5 years, Market Capitalization stood at $17.4 billion in 2022, then declined by 12.35% to $15.3 billion in 2023, then rose by 9.68% to $16.7 billion in 2024, then advanced by 13.87% to $19.1 billion in 2025, then gained by 22.7% to $23.4 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $23.4 billion in Q2 2026, $21.7 billion in Q1 2026, and $19.1 billion in Q4 2025.